Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| MNKD | CLUSTER | neutral | 3/10 | Two insiders at MannKind Corp, the EVP General Counsel and a Director, sold a combined $311K in open-market shares on Ju | Jul 17, 2026 |
| CORT | CLUSTER | neutral | 2/10 | Two Corcept Therapeutics insiders (CFO Mokari Atabak and Director James N. Wilson) sold a combined $2.59M in open-market | Jul 17, 2026 |
| CRDF | CLUSTER | mixed | 6/10 | Two insiders (CEO and a Director) purchased a total of ~$1.05M in CRDF shares at $1.455/share on July 14, two days befor | Jul 17, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | Insider selling by CEO Martine Rothblatt and EVP/General Counsel Paul Mahon totaling $8.2M, but representing only 0.036% | Jul 17, 2026 |
| PTCT | CLUSTER | neutral | 3/10 | Three PTC Therapeutics insiders, including the CFO and Chief Technical Ops Officer, sold a total of $1.40M in stock over | Jul 17, 2026 |
| TOI | CLUSTER | neutral | 3/10 | A small insider cluster at Oncology Institute (TOI) shows a 10% owner buying $88K in shares while the CMO sold $116K aft | Jul 16, 2026 |
| GILD | CLUSTER | neutral | 2/10 | Two GILD C-suite executives (CFO and Chief Communications Officer) each sold 3,000 shares in open-market transactions on | Jul 16, 2026 |
| MLYS | CLUSTER | neutral | 3/10 | CEO Jon Congleton and CMO David Malcom Rodman sold a combined $679K of MLYS stock in open-market sales on July 13, 2026, | Jul 15, 2026 |
| ORKA | CLUSTER | neutral | 2/10 | Two insiders (CMO and SVP Finance) sold shares totaling ~$1.45M, but this represents only 0.027% of the $5.3B market cap | Jul 15, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt sold ~$8.7M in open-market shares after exercising options, and Director Jan Malcolm sold $179K, t | Jul 15, 2026 |
| BCAX | CLUSTER | neutral | 2/10 | Three BCAX insiders, including the CEO and CFO, sold a total of ~$324K in shares over a 7-day window. The CEO's sales fo | Jul 15, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt executed a series of option exercises and open-market sales totaling ~$9.4M over July 10-13, 2026, | Jul 15, 2026 |
| ONC | CLUSTER | bearish | 5/10 | BeOne Medicines CEO John Oyler sold 4,139 shares and General Counsel Lee Chan Henry sold 664 shares, totaling $1.46M in | Jul 14, 2026 |
| LQDA | CLUSTER | neutral | 2/10 | Insider cluster at Liquidia Corp shows $3.16M in open-market sales by three insiders (Director Bloch, CCO Moomaw, CAO Bo | Jul 14, 2026 |
| IRON | CLUSTER | neutral | 2/10 | Two insiders at Disc Medicine (CEO and COO) sold a combined $729K in open-market shares over a one-week window. The tota | Jul 14, 2026 |
| CYTK | CLUSTER | neutral | 2/10 | Cytokinetics CEO Robert Blum exercised and sold 7,490 shares for ~$614K on July 13, and EVP R&D Fady Malik sold 3,500 sh | Jul 14, 2026 |
| BBIO | CLUSTER | neutral | 3/10 | Two BridgeBio directors executed open-market sales totaling $11.56M on July 9, 2026, following derivative exercises. Dir | Jul 14, 2026 |
| NBIX | CLUSTER | neutral | 3/10 | Two senior NBIX executives, Chief Legal Officer Darin Lippoldt and Chief Regulatory Officer Ingrid Delaet, exercised and | Jul 14, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and Director Jan Malcolm sold a combined $503K in open-market UTHR shares on July 10, 2026. The CE | Jul 14, 2026 |
| PTCT | CLUSTER | neutral | 2/10 | Two PTCT insiders, the Chief Technical Operations Officer and the EVP & CLO, sold a combined ~$267K in open-market sales | Jul 14, 2026 |
| APGE | CLUSTER | neutral | 2/10 | CEO Michael Thomas Henderson sold $2.67M and CMO Carl Dambkowski sold $730K of APGE shares in a small cluster. Combined | Jul 10, 2026 |
| EVMN | CLUSTER | neutral | 3/10 | Two Evommune insiders (Director Arthur S. Kirsch and CFO Kyle Carver) made open-market stock purchases totaling $146K ov | Jul 10, 2026 |
| PALI | CLUSTER | neutral | 2/10 | A small insider cluster at Palisade Bio (PALI) shows mixed activity: Director Baltera purchased ~$191K worth of shares o | Jul 10, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP Paul Mahon sold a combined $366K in open-market sales over a 7-day window. The CEO's sales | Jul 10, 2026 |
| AKTS | CLUSTER | neutral | 4/10 | Two C-suite insiders at Aktis Oncology (COO and CMO) executed near-simultaneous option-exercise-and-sell transactions on | Jul 10, 2026 |
| HALO | CLUSTER | neutral | 2/10 | CEO Helen Torley sold $153K in stock after exercising derivative shares at $12.07, netting a substantial cashless-settle | Jul 10, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt sold ~$7.7M in open-market shares over July 8-9, 2026, following option exercises. EVP Paul Mahon | Jul 10, 2026 |
| SION | CLUSTER | neutral | 4/10 | Three insiders at Sionna Therapeutics (SION) sold a total of $8.16M in shares over a 7-day window, representing 0.41% of | Jul 10, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and EVP Paul Mahon sold ~$1.46M in open-market UTHR shares over the past week. CEO Rothblatt's sal | Jul 9, 2026 |
| IONS | CLUSTER | neutral | 2/10 | A cluster of insider sales at Ionis Pharmaceuticals (IONS) totaling $1.36M over a 7-day window, involving the Chief Scie | Jul 9, 2026 |